ASHLEY LILIENKAMP: Open Payments
NPI 1427446202 · WEBB CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$844 in 53 payments from 14 companies in 2025. Trend: 2023 $714 · 2024 $760 · 2025 $844
Food & beverage: $844
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $269 |
| Amgen Inc. | 6 | $109 |
| Lilly USA, LLC | 5 | $80 |
| Dexcom, Inc. | 3 | $72 |
| PFIZER INC. | 4 | $71 |
| Novo Nordisk Inc | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $31 |
| Exact Sciences Corporation | 1 | $23 |
| Alkermes, Inc. | 1 | $22 |
Products named: VRAYLAR, Dexcom G6 Transmitter, MAVYRET, Ozempic, JARDIANCE, REXULTI, OTEZLA, ELIQUIS.
Industry payments across MO — which companies pay providers there.
